- Home
- AARD vs EVM Comparison
AARD vs EVM Comparison
Compare AARD & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- EVM
- Stock Information
- Founded
- AARD 2017
- EVM 2002
- Country
- AARD United States
- EVM United States
- Employees
- AARD N/A
- EVM N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- AARD Health Care
- EVM Finance
- Exchange
- AARD Nasdaq
- EVM Nasdaq
- Market Cap
- AARD 242.9M
- EVM 213.2M
- IPO Year
- AARD 2025
- EVM N/A
- Fundamental
- Price
- AARD $8.59
- EVM $9.00
- Analyst Decision
- AARD Strong Buy
- EVM
- Analyst Count
- AARD 5
- EVM 0
- Target Price
- AARD $32.60
- EVM N/A
- AVG Volume (30 Days)
- AARD 77.3K
- EVM 55.8K
- Earning Date
- AARD 08-13-2025
- EVM 01-01-0001
- Dividend Yield
- AARD N/A
- EVM 4.01%
- EPS Growth
- AARD N/A
- EVM N/A
- EPS
- AARD N/A
- EVM 0.20
- Revenue
- AARD N/A
- EVM N/A
- Revenue This Year
- AARD N/A
- EVM N/A
- Revenue Next Year
- AARD N/A
- EVM N/A
- P/E Ratio
- AARD N/A
- EVM $47.61
- Revenue Growth
- AARD N/A
- EVM N/A
- 52 Week Low
- AARD $4.88
- EVM $7.67
- 52 Week High
- AARD $19.58
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- EVM 56.97
- Support Level
- AARD N/A
- EVM $8.87
- Resistance Level
- AARD N/A
- EVM $9.14
- Average True Range (ATR)
- AARD 0.00
- EVM 0.08
- MACD
- AARD 0.00
- EVM 0.01
- Stochastic Oscillator
- AARD 0.00
- EVM 57.14
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.